ANNALS OF SURGERY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=889214, encodeId=0ce08892147f, content=审稿速度:1.0 偏重的研究方向：胃肠外科;肿瘤 经验分享：贴几个今年投的文章的status。 1# Apr 20 2020 Submitted to Journal Apr 22 2020 With Editor Apr 24 2020 Under Review May 8 2020 Required Reviews Completed May 10 2020 Decision in Process May 17 2020 Reject 2#Jun 8 2020 1:14AM Submitted to Journal Jun 9 2020 9:50PM With Editor Jun 15 2020 Decision in Process Jun 17 Reject 3# Aug 10 2020 Submitted to Journal Aug 10 2020 With Editor Aug 13 2020 Reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=mkong82, createdTime=Tue Sep 29 14:57:44 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152144, encodeId=b5d5215214410, content=请问有大佬投这个期刊，推荐转投吗？为什么没有直接告诉转投的期刊呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=949c8155801, createdName=ms2000000275921382, createdTime=Thu Aug 10 18:52:31 CST 2023, time=2023-08-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113877, encodeId=340021138e7bb, content=请问投稿提交完，合著者必须要进行确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 22:29:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2094744, encodeId=8bd22094e44f9, content=偏重的研究方向：代谢 经验分享：请问下这个杂志可以催稿吗？"With Editor”10天了，一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f48240139, createdName=ms9000000711726322, createdTime=Wed Oct 19 16:05:16 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192171, encodeId=6ffe11921e1c4, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：with editor 30多天，没送外审直接被拒。效率太低了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/27/53e8ea69cde3878f50ae689d35f1f4df.jpg, createdBy=9f3387943, createdName=oncoma, createdTime=Fri Feb 11 08:12:15 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953389, encodeId=27d09533891e, content=为什么3.30投的，现在还是submitted to journal? 😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/e0c0acd4c1714a6e8a657fd5e53d76a4/ab7ebd1a6ae24cbdb95ceb66dff657b5.jpg, createdBy=3dad2459355, createdName=Lambda.w, createdTime=Fri Apr 02 22:33:11 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588233, encodeId=e3d758823314, content=特殊时期，大概1周接收，主要问题是自己的问题，提交不成功，不然应该发过去就接收了。这个杂志还是很麻烦的，要求每个作者都要回复问卷。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epx9zgrNjgq80b0dIs6U7MpctZicI9goNMNXUn3RScicQsnkZvmiaQUcIKDDSDbhEO1AHdJdKVlTaJLQ/132, createdBy=6eac5197759, createdName=曼华8225, createdTime=Sun Apr 05 00:00:00 CST 2020, time=2020-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578602, encodeId=a12b5e86025f, content=初审得多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544393, encodeId=415c54439324, content=8-10分,已经不错了,只要长期维持在这个水平,就是国际一流期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xiaoma, createdTime=Sun Jul 16 19:09:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833146, encodeId=1c978331469c, content=非常难，一点差错都不允许。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=034d5414059, createdName=ms9701686724742584, createdTime=Wed Aug 17 16:54:38 CST 2016, time=2016-08-17, status=1, ipAttribution=)]

2020-09-29 mkong82

审稿速度:1.0
偏重的研究方向：胃肠外科;肿瘤
经验分享：贴几个今年投的文章的status。
1# Apr 20 2020 Submitted to Journal
Apr 22 2020 With Editor
Apr 24 2020 Under Review
May 8 2020 Required Reviews Completed
May 10 2020 Decision in Process
May 17 2020 Reject

2#Jun 8 2020 1:14AM Submitted to Journal
Jun 9 2020 9:50PM With Editor
Jun 15 2020 Decision in Process
Jun 17 Reject
3#
Aug 10 2020 Submitted to Journal
Aug 10 2020 With Editor
Aug 13 2020 Reject

130 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=889214, encodeId=0ce08892147f, content=审稿速度:1.0 偏重的研究方向：胃肠外科;肿瘤 经验分享：贴几个今年投的文章的status。 1# Apr 20 2020 Submitted to Journal Apr 22 2020 With Editor Apr 24 2020 Under Review May 8 2020 Required Reviews Completed May 10 2020 Decision in Process May 17 2020 Reject 2#Jun 8 2020 1:14AM Submitted to Journal Jun 9 2020 9:50PM With Editor Jun 15 2020 Decision in Process Jun 17 Reject 3# Aug 10 2020 Submitted to Journal Aug 10 2020 With Editor Aug 13 2020 Reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=mkong82, createdTime=Tue Sep 29 14:57:44 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152144, encodeId=b5d5215214410, content=请问有大佬投这个期刊，推荐转投吗？为什么没有直接告诉转投的期刊呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=949c8155801, createdName=ms2000000275921382, createdTime=Thu Aug 10 18:52:31 CST 2023, time=2023-08-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113877, encodeId=340021138e7bb, content=请问投稿提交完，合著者必须要进行确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 22:29:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2094744, encodeId=8bd22094e44f9, content=偏重的研究方向：代谢 经验分享：请问下这个杂志可以催稿吗？"With Editor”10天了，一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f48240139, createdName=ms9000000711726322, createdTime=Wed Oct 19 16:05:16 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192171, encodeId=6ffe11921e1c4, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：with editor 30多天，没送外审直接被拒。效率太低了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/27/53e8ea69cde3878f50ae689d35f1f4df.jpg, createdBy=9f3387943, createdName=oncoma, createdTime=Fri Feb 11 08:12:15 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953389, encodeId=27d09533891e, content=为什么3.30投的，现在还是submitted to journal? 😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/e0c0acd4c1714a6e8a657fd5e53d76a4/ab7ebd1a6ae24cbdb95ceb66dff657b5.jpg, createdBy=3dad2459355, createdName=Lambda.w, createdTime=Fri Apr 02 22:33:11 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588233, encodeId=e3d758823314, content=特殊时期，大概1周接收，主要问题是自己的问题，提交不成功，不然应该发过去就接收了。这个杂志还是很麻烦的，要求每个作者都要回复问卷。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epx9zgrNjgq80b0dIs6U7MpctZicI9goNMNXUn3RScicQsnkZvmiaQUcIKDDSDbhEO1AHdJdKVlTaJLQ/132, createdBy=6eac5197759, createdName=曼华8225, createdTime=Sun Apr 05 00:00:00 CST 2020, time=2020-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578602, encodeId=a12b5e86025f, content=初审得多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544393, encodeId=415c54439324, content=8-10分,已经不错了,只要长期维持在这个水平,就是国际一流期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xiaoma, createdTime=Sun Jul 16 19:09:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833146, encodeId=1c978331469c, content=非常难，一点差错都不允许。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=034d5414059, createdName=ms9701686724742584, createdTime=Wed Aug 17 16:54:38 CST 2016, time=2016-08-17, status=1, ipAttribution=)]

2023-08-10 ms2000000275921382 来自上海

请问有大佬投这个期刊，推荐转投吗？为什么没有直接告诉转投的期刊呢？

44 0

[GetPortalCommentsPageByObjectIdResponse(id=889214, encodeId=0ce08892147f, content=审稿速度:1.0 偏重的研究方向：胃肠外科;肿瘤 经验分享：贴几个今年投的文章的status。 1# Apr 20 2020 Submitted to Journal Apr 22 2020 With Editor Apr 24 2020 Under Review May 8 2020 Required Reviews Completed May 10 2020 Decision in Process May 17 2020 Reject 2#Jun 8 2020 1:14AM Submitted to Journal Jun 9 2020 9:50PM With Editor Jun 15 2020 Decision in Process Jun 17 Reject 3# Aug 10 2020 Submitted to Journal Aug 10 2020 With Editor Aug 13 2020 Reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=mkong82, createdTime=Tue Sep 29 14:57:44 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152144, encodeId=b5d5215214410, content=请问有大佬投这个期刊，推荐转投吗？为什么没有直接告诉转投的期刊呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=949c8155801, createdName=ms2000000275921382, createdTime=Thu Aug 10 18:52:31 CST 2023, time=2023-08-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113877, encodeId=340021138e7bb, content=请问投稿提交完，合著者必须要进行确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 22:29:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2094744, encodeId=8bd22094e44f9, content=偏重的研究方向：代谢 经验分享：请问下这个杂志可以催稿吗？"With Editor”10天了，一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f48240139, createdName=ms9000000711726322, createdTime=Wed Oct 19 16:05:16 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192171, encodeId=6ffe11921e1c4, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：with editor 30多天，没送外审直接被拒。效率太低了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/27/53e8ea69cde3878f50ae689d35f1f4df.jpg, createdBy=9f3387943, createdName=oncoma, createdTime=Fri Feb 11 08:12:15 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953389, encodeId=27d09533891e, content=为什么3.30投的，现在还是submitted to journal? 😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/e0c0acd4c1714a6e8a657fd5e53d76a4/ab7ebd1a6ae24cbdb95ceb66dff657b5.jpg, createdBy=3dad2459355, createdName=Lambda.w, createdTime=Fri Apr 02 22:33:11 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588233, encodeId=e3d758823314, content=特殊时期，大概1周接收，主要问题是自己的问题，提交不成功，不然应该发过去就接收了。这个杂志还是很麻烦的，要求每个作者都要回复问卷。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epx9zgrNjgq80b0dIs6U7MpctZicI9goNMNXUn3RScicQsnkZvmiaQUcIKDDSDbhEO1AHdJdKVlTaJLQ/132, createdBy=6eac5197759, createdName=曼华8225, createdTime=Sun Apr 05 00:00:00 CST 2020, time=2020-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578602, encodeId=a12b5e86025f, content=初审得多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544393, encodeId=415c54439324, content=8-10分,已经不错了,只要长期维持在这个水平,就是国际一流期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xiaoma, createdTime=Sun Jul 16 19:09:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833146, encodeId=1c978331469c, content=非常难，一点差错都不允许。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=034d5414059, createdName=ms9701686724742584, createdTime=Wed Aug 17 16:54:38 CST 2016, time=2016-08-17, status=1, ipAttribution=)]

2023-02-09 做梦也想sci 来自山东省

请问投稿提交完，合著者必须要进行确认吗？

61 0

[GetPortalCommentsPageByObjectIdResponse(id=889214, encodeId=0ce08892147f, content=审稿速度:1.0 偏重的研究方向：胃肠外科;肿瘤 经验分享：贴几个今年投的文章的status。 1# Apr 20 2020 Submitted to Journal Apr 22 2020 With Editor Apr 24 2020 Under Review May 8 2020 Required Reviews Completed May 10 2020 Decision in Process May 17 2020 Reject 2#Jun 8 2020 1:14AM Submitted to Journal Jun 9 2020 9:50PM With Editor Jun 15 2020 Decision in Process Jun 17 Reject 3# Aug 10 2020 Submitted to Journal Aug 10 2020 With Editor Aug 13 2020 Reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=mkong82, createdTime=Tue Sep 29 14:57:44 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152144, encodeId=b5d5215214410, content=请问有大佬投这个期刊，推荐转投吗？为什么没有直接告诉转投的期刊呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=949c8155801, createdName=ms2000000275921382, createdTime=Thu Aug 10 18:52:31 CST 2023, time=2023-08-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113877, encodeId=340021138e7bb, content=请问投稿提交完，合著者必须要进行确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 22:29:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2094744, encodeId=8bd22094e44f9, content=偏重的研究方向：代谢 经验分享：请问下这个杂志可以催稿吗？"With Editor”10天了，一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f48240139, createdName=ms9000000711726322, createdTime=Wed Oct 19 16:05:16 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192171, encodeId=6ffe11921e1c4, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：with editor 30多天，没送外审直接被拒。效率太低了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/27/53e8ea69cde3878f50ae689d35f1f4df.jpg, createdBy=9f3387943, createdName=oncoma, createdTime=Fri Feb 11 08:12:15 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953389, encodeId=27d09533891e, content=为什么3.30投的，现在还是submitted to journal? 😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/e0c0acd4c1714a6e8a657fd5e53d76a4/ab7ebd1a6ae24cbdb95ceb66dff657b5.jpg, createdBy=3dad2459355, createdName=Lambda.w, createdTime=Fri Apr 02 22:33:11 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588233, encodeId=e3d758823314, content=特殊时期，大概1周接收，主要问题是自己的问题，提交不成功，不然应该发过去就接收了。这个杂志还是很麻烦的，要求每个作者都要回复问卷。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epx9zgrNjgq80b0dIs6U7MpctZicI9goNMNXUn3RScicQsnkZvmiaQUcIKDDSDbhEO1AHdJdKVlTaJLQ/132, createdBy=6eac5197759, createdName=曼华8225, createdTime=Sun Apr 05 00:00:00 CST 2020, time=2020-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578602, encodeId=a12b5e86025f, content=初审得多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544393, encodeId=415c54439324, content=8-10分,已经不错了,只要长期维持在这个水平,就是国际一流期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xiaoma, createdTime=Sun Jul 16 19:09:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833146, encodeId=1c978331469c, content=非常难，一点差错都不允许。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=034d5414059, createdName=ms9701686724742584, createdTime=Wed Aug 17 16:54:38 CST 2016, time=2016-08-17, status=1, ipAttribution=)]

2022-10-19 ms9000000711726322

偏重的研究方向：代谢
经验分享：请问下这个杂志可以催稿吗？"With Editor”10天了，一点动静没有。

66 0

[GetPortalCommentsPageByObjectIdResponse(id=889214, encodeId=0ce08892147f, content=审稿速度:1.0 偏重的研究方向：胃肠外科;肿瘤 经验分享：贴几个今年投的文章的status。 1# Apr 20 2020 Submitted to Journal Apr 22 2020 With Editor Apr 24 2020 Under Review May 8 2020 Required Reviews Completed May 10 2020 Decision in Process May 17 2020 Reject 2#Jun 8 2020 1:14AM Submitted to Journal Jun 9 2020 9:50PM With Editor Jun 15 2020 Decision in Process Jun 17 Reject 3# Aug 10 2020 Submitted to Journal Aug 10 2020 With Editor Aug 13 2020 Reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=mkong82, createdTime=Tue Sep 29 14:57:44 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152144, encodeId=b5d5215214410, content=请问有大佬投这个期刊，推荐转投吗？为什么没有直接告诉转投的期刊呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=949c8155801, createdName=ms2000000275921382, createdTime=Thu Aug 10 18:52:31 CST 2023, time=2023-08-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113877, encodeId=340021138e7bb, content=请问投稿提交完，合著者必须要进行确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 22:29:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2094744, encodeId=8bd22094e44f9, content=偏重的研究方向：代谢 经验分享：请问下这个杂志可以催稿吗？"With Editor”10天了，一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f48240139, createdName=ms9000000711726322, createdTime=Wed Oct 19 16:05:16 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192171, encodeId=6ffe11921e1c4, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：with editor 30多天，没送外审直接被拒。效率太低了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/27/53e8ea69cde3878f50ae689d35f1f4df.jpg, createdBy=9f3387943, createdName=oncoma, createdTime=Fri Feb 11 08:12:15 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953389, encodeId=27d09533891e, content=为什么3.30投的，现在还是submitted to journal? 😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/e0c0acd4c1714a6e8a657fd5e53d76a4/ab7ebd1a6ae24cbdb95ceb66dff657b5.jpg, createdBy=3dad2459355, createdName=Lambda.w, createdTime=Fri Apr 02 22:33:11 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588233, encodeId=e3d758823314, content=特殊时期，大概1周接收，主要问题是自己的问题，提交不成功，不然应该发过去就接收了。这个杂志还是很麻烦的，要求每个作者都要回复问卷。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epx9zgrNjgq80b0dIs6U7MpctZicI9goNMNXUn3RScicQsnkZvmiaQUcIKDDSDbhEO1AHdJdKVlTaJLQ/132, createdBy=6eac5197759, createdName=曼华8225, createdTime=Sun Apr 05 00:00:00 CST 2020, time=2020-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578602, encodeId=a12b5e86025f, content=初审得多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544393, encodeId=415c54439324, content=8-10分,已经不错了,只要长期维持在这个水平,就是国际一流期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xiaoma, createdTime=Sun Jul 16 19:09:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833146, encodeId=1c978331469c, content=非常难，一点差错都不允许。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=034d5414059, createdName=ms9701686724742584, createdTime=Wed Aug 17 16:54:38 CST 2016, time=2016-08-17, status=1, ipAttribution=)]

2022-02-11 oncoma

审稿速度:6.0 | 投稿命中率:25.0
经验分享：with editor 30多天，没送外审直接被拒。效率太低了

90 0

[GetPortalCommentsPageByObjectIdResponse(id=889214, encodeId=0ce08892147f, content=审稿速度:1.0 偏重的研究方向：胃肠外科;肿瘤 经验分享：贴几个今年投的文章的status。 1# Apr 20 2020 Submitted to Journal Apr 22 2020 With Editor Apr 24 2020 Under Review May 8 2020 Required Reviews Completed May 10 2020 Decision in Process May 17 2020 Reject 2#Jun 8 2020 1:14AM Submitted to Journal Jun 9 2020 9:50PM With Editor Jun 15 2020 Decision in Process Jun 17 Reject 3# Aug 10 2020 Submitted to Journal Aug 10 2020 With Editor Aug 13 2020 Reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=mkong82, createdTime=Tue Sep 29 14:57:44 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152144, encodeId=b5d5215214410, content=请问有大佬投这个期刊，推荐转投吗？为什么没有直接告诉转投的期刊呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=949c8155801, createdName=ms2000000275921382, createdTime=Thu Aug 10 18:52:31 CST 2023, time=2023-08-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113877, encodeId=340021138e7bb, content=请问投稿提交完，合著者必须要进行确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 22:29:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2094744, encodeId=8bd22094e44f9, content=偏重的研究方向：代谢 经验分享：请问下这个杂志可以催稿吗？"With Editor”10天了，一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f48240139, createdName=ms9000000711726322, createdTime=Wed Oct 19 16:05:16 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192171, encodeId=6ffe11921e1c4, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：with editor 30多天，没送外审直接被拒。效率太低了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/27/53e8ea69cde3878f50ae689d35f1f4df.jpg, createdBy=9f3387943, createdName=oncoma, createdTime=Fri Feb 11 08:12:15 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953389, encodeId=27d09533891e, content=为什么3.30投的，现在还是submitted to journal? 😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/e0c0acd4c1714a6e8a657fd5e53d76a4/ab7ebd1a6ae24cbdb95ceb66dff657b5.jpg, createdBy=3dad2459355, createdName=Lambda.w, createdTime=Fri Apr 02 22:33:11 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588233, encodeId=e3d758823314, content=特殊时期，大概1周接收，主要问题是自己的问题，提交不成功，不然应该发过去就接收了。这个杂志还是很麻烦的，要求每个作者都要回复问卷。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epx9zgrNjgq80b0dIs6U7MpctZicI9goNMNXUn3RScicQsnkZvmiaQUcIKDDSDbhEO1AHdJdKVlTaJLQ/132, createdBy=6eac5197759, createdName=曼华8225, createdTime=Sun Apr 05 00:00:00 CST 2020, time=2020-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578602, encodeId=a12b5e86025f, content=初审得多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544393, encodeId=415c54439324, content=8-10分,已经不错了,只要长期维持在这个水平,就是国际一流期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xiaoma, createdTime=Sun Jul 16 19:09:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833146, encodeId=1c978331469c, content=非常难，一点差错都不允许。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=034d5414059, createdName=ms9701686724742584, createdTime=Wed Aug 17 16:54:38 CST 2016, time=2016-08-17, status=1, ipAttribution=)]

2021-04-02 Lambda.w

为什么3.30投的，现在还是submitted to journal? 😅

112 0

[GetPortalCommentsPageByObjectIdResponse(id=889214, encodeId=0ce08892147f, content=审稿速度:1.0 偏重的研究方向：胃肠外科;肿瘤 经验分享：贴几个今年投的文章的status。 1# Apr 20 2020 Submitted to Journal Apr 22 2020 With Editor Apr 24 2020 Under Review May 8 2020 Required Reviews Completed May 10 2020 Decision in Process May 17 2020 Reject 2#Jun 8 2020 1:14AM Submitted to Journal Jun 9 2020 9:50PM With Editor Jun 15 2020 Decision in Process Jun 17 Reject 3# Aug 10 2020 Submitted to Journal Aug 10 2020 With Editor Aug 13 2020 Reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=mkong82, createdTime=Tue Sep 29 14:57:44 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152144, encodeId=b5d5215214410, content=请问有大佬投这个期刊，推荐转投吗？为什么没有直接告诉转投的期刊呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=949c8155801, createdName=ms2000000275921382, createdTime=Thu Aug 10 18:52:31 CST 2023, time=2023-08-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113877, encodeId=340021138e7bb, content=请问投稿提交完，合著者必须要进行确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 22:29:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2094744, encodeId=8bd22094e44f9, content=偏重的研究方向：代谢 经验分享：请问下这个杂志可以催稿吗？"With Editor”10天了，一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f48240139, createdName=ms9000000711726322, createdTime=Wed Oct 19 16:05:16 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192171, encodeId=6ffe11921e1c4, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：with editor 30多天，没送外审直接被拒。效率太低了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/27/53e8ea69cde3878f50ae689d35f1f4df.jpg, createdBy=9f3387943, createdName=oncoma, createdTime=Fri Feb 11 08:12:15 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953389, encodeId=27d09533891e, content=为什么3.30投的，现在还是submitted to journal? 😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/e0c0acd4c1714a6e8a657fd5e53d76a4/ab7ebd1a6ae24cbdb95ceb66dff657b5.jpg, createdBy=3dad2459355, createdName=Lambda.w, createdTime=Fri Apr 02 22:33:11 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588233, encodeId=e3d758823314, content=特殊时期，大概1周接收，主要问题是自己的问题，提交不成功，不然应该发过去就接收了。这个杂志还是很麻烦的，要求每个作者都要回复问卷。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epx9zgrNjgq80b0dIs6U7MpctZicI9goNMNXUn3RScicQsnkZvmiaQUcIKDDSDbhEO1AHdJdKVlTaJLQ/132, createdBy=6eac5197759, createdName=曼华8225, createdTime=Sun Apr 05 00:00:00 CST 2020, time=2020-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578602, encodeId=a12b5e86025f, content=初审得多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544393, encodeId=415c54439324, content=8-10分,已经不错了,只要长期维持在这个水平,就是国际一流期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xiaoma, createdTime=Sun Jul 16 19:09:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833146, encodeId=1c978331469c, content=非常难，一点差错都不允许。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=034d5414059, createdName=ms9701686724742584, createdTime=Wed Aug 17 16:54:38 CST 2016, time=2016-08-17, status=1, ipAttribution=)]

2020-04-05 曼华8225

特殊时期，大概1周接收，主要问题是自己的问题，提交不成功，不然应该发过去就接收了。这个杂志还是很麻烦的，要求每个作者都要回复问卷。

134 0

[GetPortalCommentsPageByObjectIdResponse(id=889214, encodeId=0ce08892147f, content=审稿速度:1.0 偏重的研究方向：胃肠外科;肿瘤 经验分享：贴几个今年投的文章的status。 1# Apr 20 2020 Submitted to Journal Apr 22 2020 With Editor Apr 24 2020 Under Review May 8 2020 Required Reviews Completed May 10 2020 Decision in Process May 17 2020 Reject 2#Jun 8 2020 1:14AM Submitted to Journal Jun 9 2020 9:50PM With Editor Jun 15 2020 Decision in Process Jun 17 Reject 3# Aug 10 2020 Submitted to Journal Aug 10 2020 With Editor Aug 13 2020 Reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=mkong82, createdTime=Tue Sep 29 14:57:44 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152144, encodeId=b5d5215214410, content=请问有大佬投这个期刊，推荐转投吗？为什么没有直接告诉转投的期刊呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=949c8155801, createdName=ms2000000275921382, createdTime=Thu Aug 10 18:52:31 CST 2023, time=2023-08-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113877, encodeId=340021138e7bb, content=请问投稿提交完，合著者必须要进行确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 22:29:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2094744, encodeId=8bd22094e44f9, content=偏重的研究方向：代谢 经验分享：请问下这个杂志可以催稿吗？"With Editor”10天了，一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f48240139, createdName=ms9000000711726322, createdTime=Wed Oct 19 16:05:16 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192171, encodeId=6ffe11921e1c4, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：with editor 30多天，没送外审直接被拒。效率太低了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/27/53e8ea69cde3878f50ae689d35f1f4df.jpg, createdBy=9f3387943, createdName=oncoma, createdTime=Fri Feb 11 08:12:15 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953389, encodeId=27d09533891e, content=为什么3.30投的，现在还是submitted to journal? 😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/e0c0acd4c1714a6e8a657fd5e53d76a4/ab7ebd1a6ae24cbdb95ceb66dff657b5.jpg, createdBy=3dad2459355, createdName=Lambda.w, createdTime=Fri Apr 02 22:33:11 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588233, encodeId=e3d758823314, content=特殊时期，大概1周接收，主要问题是自己的问题，提交不成功，不然应该发过去就接收了。这个杂志还是很麻烦的，要求每个作者都要回复问卷。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epx9zgrNjgq80b0dIs6U7MpctZicI9goNMNXUn3RScicQsnkZvmiaQUcIKDDSDbhEO1AHdJdKVlTaJLQ/132, createdBy=6eac5197759, createdName=曼华8225, createdTime=Sun Apr 05 00:00:00 CST 2020, time=2020-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578602, encodeId=a12b5e86025f, content=初审得多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544393, encodeId=415c54439324, content=8-10分,已经不错了,只要长期维持在这个水平,就是国际一流期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xiaoma, createdTime=Sun Jul 16 19:09:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833146, encodeId=1c978331469c, content=非常难，一点差错都不允许。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=034d5414059, createdName=ms9701686724742584, createdTime=Wed Aug 17 16:54:38 CST 2016, time=2016-08-17, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

初审得多长时间

144 0

[GetPortalCommentsPageByObjectIdResponse(id=889214, encodeId=0ce08892147f, content=审稿速度:1.0 偏重的研究方向：胃肠外科;肿瘤 经验分享：贴几个今年投的文章的status。 1# Apr 20 2020 Submitted to Journal Apr 22 2020 With Editor Apr 24 2020 Under Review May 8 2020 Required Reviews Completed May 10 2020 Decision in Process May 17 2020 Reject 2#Jun 8 2020 1:14AM Submitted to Journal Jun 9 2020 9:50PM With Editor Jun 15 2020 Decision in Process Jun 17 Reject 3# Aug 10 2020 Submitted to Journal Aug 10 2020 With Editor Aug 13 2020 Reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=mkong82, createdTime=Tue Sep 29 14:57:44 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152144, encodeId=b5d5215214410, content=请问有大佬投这个期刊，推荐转投吗？为什么没有直接告诉转投的期刊呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=949c8155801, createdName=ms2000000275921382, createdTime=Thu Aug 10 18:52:31 CST 2023, time=2023-08-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113877, encodeId=340021138e7bb, content=请问投稿提交完，合著者必须要进行确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 22:29:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2094744, encodeId=8bd22094e44f9, content=偏重的研究方向：代谢 经验分享：请问下这个杂志可以催稿吗？"With Editor”10天了，一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f48240139, createdName=ms9000000711726322, createdTime=Wed Oct 19 16:05:16 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192171, encodeId=6ffe11921e1c4, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：with editor 30多天，没送外审直接被拒。效率太低了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/27/53e8ea69cde3878f50ae689d35f1f4df.jpg, createdBy=9f3387943, createdName=oncoma, createdTime=Fri Feb 11 08:12:15 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953389, encodeId=27d09533891e, content=为什么3.30投的，现在还是submitted to journal? 😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/e0c0acd4c1714a6e8a657fd5e53d76a4/ab7ebd1a6ae24cbdb95ceb66dff657b5.jpg, createdBy=3dad2459355, createdName=Lambda.w, createdTime=Fri Apr 02 22:33:11 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588233, encodeId=e3d758823314, content=特殊时期，大概1周接收，主要问题是自己的问题，提交不成功，不然应该发过去就接收了。这个杂志还是很麻烦的，要求每个作者都要回复问卷。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epx9zgrNjgq80b0dIs6U7MpctZicI9goNMNXUn3RScicQsnkZvmiaQUcIKDDSDbhEO1AHdJdKVlTaJLQ/132, createdBy=6eac5197759, createdName=曼华8225, createdTime=Sun Apr 05 00:00:00 CST 2020, time=2020-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578602, encodeId=a12b5e86025f, content=初审得多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544393, encodeId=415c54439324, content=8-10分,已经不错了,只要长期维持在这个水平,就是国际一流期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xiaoma, createdTime=Sun Jul 16 19:09:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833146, encodeId=1c978331469c, content=非常难，一点差错都不允许。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=034d5414059, createdName=ms9701686724742584, createdTime=Wed Aug 17 16:54:38 CST 2016, time=2016-08-17, status=1, ipAttribution=)]

2017-07-16 xiaoma

8-10分,已经不错了,只要长期维持在这个水平,就是国际一流期刊

363 0

[GetPortalCommentsPageByObjectIdResponse(id=889214, encodeId=0ce08892147f, content=审稿速度:1.0 偏重的研究方向：胃肠外科;肿瘤 经验分享：贴几个今年投的文章的status。 1# Apr 20 2020 Submitted to Journal Apr 22 2020 With Editor Apr 24 2020 Under Review May 8 2020 Required Reviews Completed May 10 2020 Decision in Process May 17 2020 Reject 2#Jun 8 2020 1:14AM Submitted to Journal Jun 9 2020 9:50PM With Editor Jun 15 2020 Decision in Process Jun 17 Reject 3# Aug 10 2020 Submitted to Journal Aug 10 2020 With Editor Aug 13 2020 Reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=mkong82, createdTime=Tue Sep 29 14:57:44 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152144, encodeId=b5d5215214410, content=请问有大佬投这个期刊，推荐转投吗？为什么没有直接告诉转投的期刊呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=949c8155801, createdName=ms2000000275921382, createdTime=Thu Aug 10 18:52:31 CST 2023, time=2023-08-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113877, encodeId=340021138e7bb, content=请问投稿提交完，合著者必须要进行确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Thu Feb 09 22:29:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2094744, encodeId=8bd22094e44f9, content=偏重的研究方向：代谢 经验分享：请问下这个杂志可以催稿吗？"With Editor”10天了，一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f48240139, createdName=ms9000000711726322, createdTime=Wed Oct 19 16:05:16 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192171, encodeId=6ffe11921e1c4, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：with editor 30多天，没送外审直接被拒。效率太低了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/27/53e8ea69cde3878f50ae689d35f1f4df.jpg, createdBy=9f3387943, createdName=oncoma, createdTime=Fri Feb 11 08:12:15 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953389, encodeId=27d09533891e, content=为什么3.30投的，现在还是submitted to journal? 😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/e0c0acd4c1714a6e8a657fd5e53d76a4/ab7ebd1a6ae24cbdb95ceb66dff657b5.jpg, createdBy=3dad2459355, createdName=Lambda.w, createdTime=Fri Apr 02 22:33:11 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588233, encodeId=e3d758823314, content=特殊时期，大概1周接收，主要问题是自己的问题，提交不成功，不然应该发过去就接收了。这个杂志还是很麻烦的，要求每个作者都要回复问卷。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epx9zgrNjgq80b0dIs6U7MpctZicI9goNMNXUn3RScicQsnkZvmiaQUcIKDDSDbhEO1AHdJdKVlTaJLQ/132, createdBy=6eac5197759, createdName=曼华8225, createdTime=Sun Apr 05 00:00:00 CST 2020, time=2020-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578602, encodeId=a12b5e86025f, content=初审得多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544393, encodeId=415c54439324, content=8-10分,已经不错了,只要长期维持在这个水平,就是国际一流期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xiaoma, createdTime=Sun Jul 16 19:09:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833146, encodeId=1c978331469c, content=非常难，一点差错都不允许。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=034d5414059, createdName=ms9701686724742584, createdTime=Wed Aug 17 16:54:38 CST 2016, time=2016-08-17, status=1, ipAttribution=)]

2016-08-17 ms9701686724742584

非常难，一点差错都不允许。

64 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务